Profusa (PFSA)

NASDAQ:PFSA

PFSA

Profusa

RESEARCH TOOLSreports

Profusa (PFSA) Price & Analysis

Q: What was Profusa’s price range in the past 12 months?

Profusa lowest stock price was $0.26 and its highest was $938.25 in the past 12 months.

Q: What is Profusa’s market cap?

Profusa’s market cap is $1.25M.

Q: When is Profusa’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Q: Is Profusa overvalued?

According to Wall Street analysts Profusa’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Profusa pay dividends?

Profusa does not currently pay dividends.

Q: What is Profusa’s EPS estimate?

Profusa’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Profusa have?

Profusa has 4,660,268 shares outstanding.

Q: Which hedge fund is a major shareholder of Profusa?

Currently, no hedge funds are holding shares in PFSA

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

90 Followers

PFSA Stock Chart & Stats

$0.69

Market closed

$0.69

Day’s Range― - ―

52-Week Range$0.26 - $938.25

Previous CloseN/A

VolumeN/A

Average Volume (3M)11.18M

Market Cap

$1.25M

Enterprise Value$12.36M

Total Cash (Recent Filing)$375.00K

Total Debt (Recent Filing)$12.54M

Price to Earnings (P/E)―

Beta1.10

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding4,660,268

10 Day Avg. Volume2,452,317

30 Day Avg. Volume11,175,155

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)-0.10

Price to Sales (P/S)0.00

P/FCF Ratio-0.16

Enterprise Value/Market Cap9.88

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-0.36

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Profusa News

Profusa to transfer listing to Nasdaq

Profusa (PFSA)announced that, effective May 15, the company will now be listed on Nasdaq. Published first on TheFly...

25d ago

PFSA

Profusa Taps Equity Line With Dilutive True-Up Mechanism

Profusa ( ($PFSA) ) has shared an update. On June 8, 2026, Profusa, Inc. submitted an Advance Notice...

15h ago

PFSA

Profusa Amends PanOmics Acquisition Terms to Reduce Dilution

Profusa ( ($PFSA) ) has shared an announcement. On May 22, 2026, Profusa Inc. and Bio Insights LLC...

13d ago

PFSA

Profusa Taps Equity Line for Near-Term Liquidity

An announcement from Profusa ( ($PFSA) ) is now available. On May 18, 2026, Profusa, Inc. submitted an...

21d ago

PFSA

Profusa Transfers Nasdaq Listing Amid Ongoing Compliance Uncertainty

Profusa ( ($PFSA) ) just unveiled an update. On May 13, 2026, Profusa received confirmation from Nasdaq that...

25d ago

PFSA

Profusa Granted Conditional Nasdaq Listing Extension and Transfer

Profusa ( ($PFSA) ) has shared an update. On May 6, 2026, Profusa, Inc. received a decision from...

1M ago

PFSA

Profusa receives favorable Nasdaq listing determination

Profusa (PFSA)announced that, by letter dated May 6, the Nasdaq Hearings Panel granted the company’s request to transfer...

1M ago

PFSA

Profusa Faces Nasdaq Listing Risk Amid Financing Amendments

Profusa ( ($PFSA) ) has provided an update. On April 24, 2026, Profusa, Inc. amended a $2.5 million...

1M ago

PFSA

Profusa Announces PanOmics Assay Know-How Acquisition Agreement

Profusa ( ($PFSA) ) just unveiled an update. On April 21, 2026, Profusa Inc. agreed to acquire substantially...

1M ago

PFSA

Profusa Secures New Convertible Note and Warrant Financing

The latest update is out from Profusa ( ($PFSA) ). On April 20, 2026, Profusa completed an additional...

2M ago

PFSA

Profusa Amends Financing and Pursues PanOmics Acquisition

Profusa ( ($PFSA) ) has provided an announcement. On April 2, 2026, Profusa amended its existing securities purchase...

2M ago

PFSA

Profusa announces $30M letter of intent for PanOmics diagnostic platform

Profusa (PFSA)announced a strategic expansion into molecular diagnostics through a Letter of Intent to acquire the PanOmics multi-omics...

2M ago

PFSA

PFSA FAQ

What was Profusa’s price range in the past 12 months?

Profusa lowest stock price was $0.26 and its highest was $938.25 in the past 12 months.

What is Profusa’s market cap?

Profusa’s market cap is $1.25M.

When is Profusa’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Profusa’s earnings last quarter?

Currently, no data Available

Is Profusa overvalued?

According to Wall Street analysts Profusa’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Profusa pay dividends?

Profusa does not currently pay dividends.

What is Profusa’s EPS estimate?

Profusa’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Profusa have?

Profusa has 4,660,268 shares outstanding.

What happened to Profusa’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Profusa?

Currently, no hedge funds are holding shares in PFSA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Profusa

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.